CN114015642A - Bovine follicular granulosa cell in-vitro culture regulator and application thereof - Google Patents

Bovine follicular granulosa cell in-vitro culture regulator and application thereof Download PDF

Info

Publication number
CN114015642A
CN114015642A CN202111253321.9A CN202111253321A CN114015642A CN 114015642 A CN114015642 A CN 114015642A CN 202111253321 A CN202111253321 A CN 202111253321A CN 114015642 A CN114015642 A CN 114015642A
Authority
CN
China
Prior art keywords
bovine
adrenocorticotropic hormone
cells
bovine follicular
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111253321.9A
Other languages
Chinese (zh)
Inventor
刘彦
杨婷
许晓玲
白佳桦
冯涛
秦玉圣
宋玉清
肖霖力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Academy of Agriculture and Forestry Sciences
Original Assignee
Beijing Academy of Agriculture and Forestry Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Academy of Agriculture and Forestry Sciences filed Critical Beijing Academy of Agriculture and Forestry Sciences
Priority to CN202111253321.9A priority Critical patent/CN114015642A/en
Publication of CN114015642A publication Critical patent/CN114015642A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/85Hormones derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C12N2501/855Corticotropin [ACTH]

Abstract

The invention provides a regulator for in vitro culture of bovine follicular granulosa cells and application thereof, wherein the regulator contains adrenocorticotropic hormone (ACTH). When the bovine follicular granular cells are cultured by using the in-vitro culture solution added with the adrenocorticotropic hormone, the adrenocorticotropic hormone can promote the synthesis of progesterone of the bovine follicular granular cells, the adrenocorticotropic hormone can down-regulate the expression of a P450arom gene and up-regulate the expression of a P450scc gene, but the adrenocorticotropic hormone has no influence on the expression of a StAR gene and a 3 beta-HSD gene. Adrenocorticotropic hormone is used as an endocrine regulatory factor of the bovine ovarian function, and the synthesis of steroid hormone is up-regulated to promote the differentiation of granular cells. The adrenocorticotropic hormone is applied to a preparation for enhancing the synthesis of the steroid of the bovine follicular granular cells, and has good application value.

Description

Bovine follicular granulosa cell in-vitro culture regulator and application thereof
Technical Field
The invention belongs to the technical field of livestock gamete embryo engineering, and particularly relates to a bovine follicular granular cell in-vitro culture regulator and application thereof.
Background
The follicular granulosa cell is the most important somatic cell in the follicle and plays an important role in local microenvironment regulation of the follicle. Early granulosa cells are differentiated from follicular epithelial cells. Granulosa cells, as important steroid hormone synthetic cells, can promote ovary synthesis and secretion of multiple hormones and growth factors such as estrogen and progestogen, regulate and control the growth, differentiation and maturation of theca cells and oocytes through gap connection, and further regulate and control the processes of follicular development, maturation, ovulation, follicular atresia and the like.
Cows are capable of inducing adrenocortical hormone secretion under various stress conditions by activating the hypothalamic-pituitary-adrenal axis (Dobson et al, 2000). Corticosteroids decrease the pulse frequency of LH secretion and eventually the preovulatory LH surge does not occur, leading to ovulation failure and induction of ovarian cysts (Dobson et al, 2006; Ribadu et al, 2000; Colitti et al, 2007; Paredes et al, 2011). Ovarian cyst is one of the most common reasons for causing the infertility of dairy cows, seriously influences the breeding efficiency of the dairy cows and restricts the development of dairy farms and the economic benefits of breeding industries. According to foreign research reports, the incidence of ovarian cyst is 6.7% -13.1% (Wiltbank et al, 2002). Ovarian cyst can reduce conception rate, prolong calving interval, increase breeding times and elimination rate, thereby affecting the fertility of dairy cows, finally reducing the economic benefit of dairy farms and causing serious economic loss to the dairy industry.
Exogenous adrenocorticotropic hormone (ACTH) can induce cow to generate follicular cyst, and changes the pulse frequency of LH secretion mainly by activating hypothalamus-pituitary-adrenal axis, so that the pre-ovulation LH peak cannot appear but cannot ovulate, and then ovarian cyst is formed, and the mechanism of the ovarian cyst is consistent with that of ovarian cyst caused by stress (Amweg et al, 2013; Biran et al, 2015; Velazquez et al, 2013). The former research mostly develops from the change of follicular follicle in milk cow, hormone and receptor gene expression, and although some progress is made, in the production practice, when the follicular cyst is confirmed, the hormone and gene expression change shown in the research cannot completely explain the abnormal change state of the body when the follicular follicle cannot normally ovulate in time, and the unpredictability of follicular cyst formation causes certain difficulty for a researcher to analyze the molecular mechanism formed by the follicular cyst. At present, no report is available on the effect of corticotropin on bovine follicular granulosa cells.
Disclosure of Invention
The invention aims to provide an in vitro culture regulator for bovine follicular granular cells, which is used for promoting the in vitro culture and synthesis of progesterone by the bovine follicular granular cells.
The invention also aims to provide a new application of the adrenocorticotropic hormone, in particular to an application of the adrenocorticotropic hormone in promoting the synthesis of the progesterone of the bovine follicular granular cell.
In order to achieve the purpose, the invention adopts the following technical scheme that:
an in vitro culture regulator of bovine follicular granulosa cell for promoting in vitro culture of bovine follicular granulosa cell to synthesize progesterone, which comprises a progesterone content of 10%-10~10-6A basal culture solution of adrenocorticotropic hormone in mol/L.
The regulator for in vitro culture of bovine follicular granular cells as described above, preferably, the basal medium is a mixture of DMEM and Ham's F-12 at a volume ratio of 1: 1.
The regulator for in vitro culture of bovine follicular granulosa cells as described above, wherein the basic culture medium further comprises 10% by volume of fetal bovine serum, penicillin at a concentration of 100U/mL and streptomycin at a concentration of 0.1 mg/mL.
As described abovePreferably, the concentration of the adrenocorticotropic hormone is 10-7mol/L。
The regulator for in vitro culture of bovine follicular granular cells as described above, preferably wherein the corticotropin is a recombinant murine corticotropin protein.
A culture method for promoting the in vitro differentiation of bovine follicular granulosa cells, comprising culturing bovine follicular granulosa cells in the in vitro culture regulator for bovine follicular granulosa cells as described above.
Application of adrenocorticotropic hormone in promoting in-vitro synthesis of steroid hormone by bovine follicular granular cells.
Application of adrenocorticotropic hormone in preparing medicine for promoting bovine follicular granular cell differentiation in vitro.
Application of adrenocorticotropic hormone in promoting in-vitro synthesis of progesterone by bovine follicular granular cells.
Preferably, the corticotropin is used in the concentration of 10 in the in vitro culture of bovine follicular granulosa cells-10~10-6mol/L。
Further, preferably, the adrenocorticotropic hormone is used at a concentration of 10 in the in vitro culture of bovine follicular granulosa cells-7mol/L。
As mentioned above, preferably, the culture medium used for the in vitro culture of the bovine follicular granular cells is a basal medium containing DMEM and Ham's F-12 culture solution at a volume ratio of 1:1, and fetal bovine serum at a volume ratio of 10%, penicillin at a concentration of 100U/mL and streptomycin at a concentration of 0.1mg/mL are added.
The invention has the beneficial effects that:
the invention provides a regulator for in-vitro culture of bovine follicular granulosa cells, which is used for promoting the expression of P450scc and inhibiting the expression of P450arom by adrenocorticotropic hormone when the bovine follicular granulosa cells are cultured in vitro, but has no influence on StAR and 3 beta-HSD expression. Adrenocorticotropic hormone is used as an endocrine regulatory factor of the bovine ovarian function, and the differentiation of granulosa cells is accelerated by up-regulating the synthesis of steroid hormone.
The invention provides a new application of corticotropin, which is used for promoting the synthesis of progesterone in the in vitro culture of bovine follicle-stimulating cells. Furthermore, the adrenocorticotropic hormone is applied to a preparation for promoting the synthesis of the steroid of the bovine follicular granular cells, so that the application value is good. The adrenocorticotropic hormone can be used as a novel pharmaceutical preparation for promoting the synthesis of steroid hormone by cow follicle granular cells and popularized and applied to livestock embryo engineering.
Drawings
FIG. 1 is a graph comparing the synthesis of progesterone by granulosa cells treated with IGF1 at different concentrations of corticotropin.
FIG. 2 is a graph showing the results of P450scc gene expression in granulosa cells in the absence and presence of corticotropin when IGF1 was added in total.
FIG. 3 is a graph showing the results of the expression of granulosa cell P450arom gene in the absence and presence of corticotropin when IGF1 was added in total.
FIG. 4 is a graph showing the results of StAR gene expression in granulosa cells in the absence and addition of corticotropin when IGF1 was added in total.
FIG. 5 is a graph showing the results of the expression of the granulosa cell 3 β -HSD gene in the absence and presence of corticotropin when IGF1 was added in total.
In the above figures, the difference (P <0.05) is indicated by mol/L abbreviated as M.
Detailed Description
The following examples are intended to further illustrate the invention but should not be construed as limiting it. Modifications and substitutions may be made thereto without departing from the spirit and scope of the invention.
Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art. The ovary used in the embodiment of the invention is collected from slaughterhouses in big factories and counties of Hebei province, and the adrenocorticotropic hormone is synthesized by Nanjing Laong biotechnology limited. The reagent sources used were as follows: ham's F-12(F12), DMEM medium, Fetal Bovine Serum (FBS) from Gibco (shanghai), recombinant human IGF-1 from Science 11(San Diego, CA), bovine progesterone Radioimmunoassay (RIA): the research institute of biotechnology in Beijing northern, RNA detection reagent: one-chain synthesis kit and fluorescent quantitative kit (Tiangen Biochemical technology Co., Ltd., Beijing) are used, and the adrenocorticotropic hormone used is recombinant murine adrenocorticotropic hormone protein.
Example 1 Effect of adrenocorticotropic hormone on the Synthesis of steroid hormones in bovine follicular granulosa cells
1. Cell culture
Ovaries were collected at slaughter, placed in 0.9% saline containing penicillin and streptomycin at concentrations of 100IU/mL, kept at 37 ℃ with a vacuum flask and transported back to the laboratory over 2 hours. A10 mL syringe is used for extracting liquid in a follicle with the length of 3-8 mm from the surface of a cow ovary obtained from a slaughterhouse, the blood vessel of the follicle is required to be clear, and the follicular liquid is required to be transparent. The follicular fluid was collected in a 15mL centrifuge tube and then centrifuged at 500g for 5min, the cells were pelleted at the bottom of the tube and the supernatant removed. Granulosa cells were isolated from medium sized follicles 3-8 mm in diameter. Resuspend cells in PBS buffer, and repeat this centrifugation 4 times. The cells were resuspended in DMEM medium containing 10% fetal bovine serum and filtered through a 200 mesh filter screen to remove cell clumps, yielding granulocytes with a purity greater than 90%.
The granulocytes were counted with a cell counter and approximately 2X 10-fold plated with 5mL of a culture medium containing 10% fetal bovine serum (10% FBS)5cells/mL, in 5% CO2And (3) standing and culturing in an incubator at 37 ℃, wherein the granular cells can adhere to the wall after 12 hours generally, and changing the culture solution after the adherence of the cells is observed. The culture medium was changed every 24 hours.
When cell growth fused to more than 80%, the culture broth was discarded, followed by 2 rinses with PBS. Adding 1mL of 0.25% trypsin digestion solution, digesting at 37 ℃ for 3min, observing cell contraction and rounding under a microscope, and adding 1mL of culture solution containing 10% fetal bovine serum (10% FBS) to terminate digestion; collecting cells in a centrifuge tube, centrifuging at 1500rpm for 5min, collecting precipitate, washing with PBS 3 times, re-suspending the collected cells with culture solution, counting, and performing 1 × 105The cells/mL were plated in 12-well plates at 37 ℃ with 5% CO2Culturing in an incubator.
Wherein the 10% FBS culture solution is DMEM and Ham's F-12 at a volume ratio of 1:1 as basal medium, and is added with 10% fetal bovine serum, penicillin at a concentration of 100U/ml and streptomycin at a concentration of 0.1 mg/ml.
2. Treatment of bovine follicular granulosa cells with corticotropin
Culturing the granular cells obtained in the step 1 in a culture solution containing 10% FBS by volume for 24 hours, discarding the culture solution, washing with PBS for 2 times, and respectively using the PBS containing the granular cells with the concentration of 0 and 10 percent-6、10-7、10-8、10-9、10-10And (3) treating the culture solution for 48 hours in serum-free culture solution containing mol/L adrenocorticotropic hormone (ACTH). After the culture was completed, the culture solution was collected for measurement of progesterone content. This experiment was designed for 3 different replicates. Wherein the serum-free culture solution is a mixture of DMEM and Ham's F-12 at a volume ratio of 1:1, does not contain fetal bovine serum, and contains 100U/ml penicillin and 0.1mg/ml streptomycin.
3. Detection assay
Progesterone was measured by radioimmunoassay.
Progesterone hormone secretion levels were analyzed by one-way factor ANOVA in SPSS software. Data are expressed as mean ± sem. Progesterone hormone is expressed as ng/mL. The results of the assay are shown in FIG. 1 and demonstrate that corticotropin enhances progesterone synthesis in granulosa cells.
Example 2 Effect of corticotropin on P450scc, P450arom, StAR, 3 β -HSD mRNA expression
1. Cell culture
Granular cells obtained by cell culture according to example 1 were cultured in a culture medium containing 10% FBS by volume for 24 hours, and then the culture medium was discarded and washed 2 times with PBS at concentrations of 0 and 10-6、10-7、10-8、10-9、10-10Treating with mol/L adrenocorticotropic hormone in serum-free culture solution for 48h, collecting the culture solution, and splitting cellsAfter being resolved, the RNA is used for extraction. Experimental design 3 different replicates were averaged.
RNA extraction and RT-PCR quantitative determination of expression level
After the culture is finished, sucking the culture solution of each hole; 0.5mL of TRIzol reagent (Tiangen Biochemical technology Co., Ltd., Beijing) was added to the wells, and RNA was extracted. The RNA samples were measured for absorbance at 260nm using a TECAN microplate detector (Tecan Group Ltd., Mannedorf, Switzerland) and diluted with DEPC water and stored at-80 ℃.
P450scc, P450arom, StAR and 3 β -HSD gene primers are described in published literature (Hilda M et al, 2017; the Su et al, 2017). The primers were synthesized by Shanghai bioengineering, Inc. Three replicates per sample. Housekeeping gene GAPDH was used as the reference gene. Adopts a relative quantitative method 2-△△CtThe formula compares the expression levels of the mRNA of the genes of interest.
3. The result of the detection
Analysis of gene expression data was performed using ANOVA in SPSS software and data are presented as mean. + -. standard error.
The results are shown in FIGS. 2-5, where cytochrome P450 aromatase (P450arom), a member of the P450 cytochrome enzyme superfamily, is a key enzyme in the steroid hormone production pathway, which catalyzes the biosynthesis of estrogen from androgen. The regulation of this gene directly affects the efficiency of androgen to estrogen conversion. The StAR gene encodes steroid hormone acute regulatory protein, which can act on the outer mitochondrial membrane, mediate and promote the transfer of cholesterol substrate from the outer mitochondrial membrane to the inner membrane, then is converted into pregnenolone under the action of cholesterol side chain lyase P450scc, enters cytoplasm after being transferred out of mitochondria, and is converted into progestogen under the action of 3 beta-HSD. The synthesis of progestagen is under multiple regulation by StAR, P450scc, 3 beta-HSD, etc.
The results show that the expression of StAR and 3 beta-HSD genes is not changed when the adrenocorticotropic hormone is used for treating the bovine follicular granulosa cells. Corticotropin can inhibit P450arom gene expression and promote P450scc gene expression (P < 0.05). Thus, it can be seen that corticotropin can regulate bovine ovarian granulosa cell function, promote progesterone synthesis by up-regulating steroid synthesis related gene P450scc, and possibly inhibit estrogen synthesis by down-regulating expression of P450arom gene.

Claims (10)

1. An in vitro culture regulator for bovine follicular granulosa cells, which is used for promoting in vitro culture of bovine follicular granulosa cells to synthesize progesterone and comprises a progesterone content with a concentration of 10%-10~10-6A basal culture solution of adrenocorticotropic hormone in mol/L.
2. The regulator of claim 1, wherein the basal medium is a mixture of DMEM and Ham's F-12 at a volume ratio of 1: 1.
3. The regulator of claim 2, wherein the basic culture medium further comprises 10% by volume of fetal bovine serum, penicillin at a concentration of 100U/mL and streptomycin at a concentration of 0.1mg/mL, and the adrenocorticotropic hormone is recombinant murine adrenocorticotropic hormone protein.
4. A culture method for promoting the in vitro differentiation of bovine follicular granulosa cells, comprising culturing bovine follicular granulosa cells in the in vitro culture regulator of bovine follicular granulosa cells according to claims 1-4.
5. Application of adrenocorticotropic hormone in promoting in-vitro synthesis of steroid hormone by bovine follicular granular cells.
6. Application of adrenocorticotropic hormone in preparing medicine for promoting bovine follicular granular cell differentiation in vitro.
7. Application of adrenocorticotropic hormone in promoting in-vitro synthesis of progesterone by bovine follicular granular cells.
8. Use according to claim 7Wherein said corticotropin is used in a concentration of 10 in the in vitro culture of bovine follicular granulosa cells-10~10-6mol/L。
9. The use according to claim 7, wherein the corticotropin is used in a concentration of 10 in the in vitro culture of bovine follicular granulosa cells-7mol/L。
10. The use according to claim 7, wherein the culture medium used for the in vitro culture of bovine follicular granulosa cells is a basal medium comprising DMEM and Ham's F-12 in a volume ratio of 1:1, supplemented with 10% by volume fetal bovine serum and penicillin at a concentration of 100U/mL and streptomycin at a concentration of 0.1 mg/mL.
CN202111253321.9A 2021-10-27 2021-10-27 Bovine follicular granulosa cell in-vitro culture regulator and application thereof Pending CN114015642A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111253321.9A CN114015642A (en) 2021-10-27 2021-10-27 Bovine follicular granulosa cell in-vitro culture regulator and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111253321.9A CN114015642A (en) 2021-10-27 2021-10-27 Bovine follicular granulosa cell in-vitro culture regulator and application thereof

Publications (1)

Publication Number Publication Date
CN114015642A true CN114015642A (en) 2022-02-08

Family

ID=80057872

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111253321.9A Pending CN114015642A (en) 2021-10-27 2021-10-27 Bovine follicular granulosa cell in-vitro culture regulator and application thereof

Country Status (1)

Country Link
CN (1) CN114015642A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070292427A1 (en) * 2006-05-09 2007-12-20 Khan Shafiq A Substantially pure steroidogenesis inducing peptide and uses thereof
US20160145579A1 (en) * 2006-03-08 2016-05-26 Kwalata Trading Limited Regulating stem cells
CN108342352A (en) * 2018-04-20 2018-07-31 北京市农林科学院 Application of the N- carbamylglutamic acids in pig follicle granular cell in vitro culture

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160145579A1 (en) * 2006-03-08 2016-05-26 Kwalata Trading Limited Regulating stem cells
US20070292427A1 (en) * 2006-05-09 2007-12-20 Khan Shafiq A Substantially pure steroidogenesis inducing peptide and uses thereof
CN108342352A (en) * 2018-04-20 2018-07-31 北京市农林科学院 Application of the N- carbamylglutamic acids in pig follicle granular cell in vitro culture

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘宇等: "牦牛StAR基因克隆及其生物信息学与组织表达特性的研究", 畜牧兽医学报, vol. 52, no. 9, pages 2452 - 2463 *
杜娟等: "内皮缩血管肽1和促肾上腺皮质激素对培养的正常人黑素细胞增殖的影响", 中华皮肤科杂志, vol. 39, no. 2, pages 77 - 79 *
蒋小涵: "LRH-1对牛卵巢颗粒细胞凋亡及类固醇激素分泌的调控", 硕士电子期刊库, no. 09, pages 1 - 76 *

Similar Documents

Publication Publication Date Title
Liu et al. Resveratrol improves in vitro maturation of oocytes in aged mice and humans
Zeron et al. Seasonal changes in bovine fertility: relation to developmental competence of oocytes, membrane properties and fatty acid composition of follicles
Meidan et al. In vitro differentiation of bovine theca and granulosa cells into small and large luteal-like cells: morphological and functional characteristics
Smitz et al. Effects of recombinant activin A on in vitro culture of mouse preantral follicles
CN110577931B (en) Intermittent hypoxia treatment stem cell source exosome and application thereof in myocardial tissues
Zheng et al. Role of transforming growth factor-b1 in gene expression and activity of estradiol and progesterone-generating enzymes in FSH-stimulated bovine granulosa cells
CN107034177B (en) Bovine vacuolar membrane cell in-vitro culture regulator and application thereof
Qu et al. ROS-induced GATA4 and GATA6 downregulation inhibits StAR expression in LPS-treated porcine granulosa-lutein cells
CN111748559B (en) Application of CTNNB1 gene in porcine ovary granular cells
CN114015642A (en) Bovine follicular granulosa cell in-vitro culture regulator and application thereof
CN111254110A (en) Method for transdifferentiation of mesenchymal stem cells into sperms
CN113913508B (en) Application of miR-195-3p detection reagent in preparation of product for diagnosing oxidative stress injury of liver
Liu et al. Oleate induces transdifferentiation of chicken fibroblasts into adipocyte-like cells
Gómez et al. Follicle-stimulating hormone regulates steroidogenic enzymes in cultured cells of the chick embryo ovary
CN113969259A (en) Separation method of Leydig cells in rat testis stroma
Doldi et al. Polycystic ovary syndrome: evidence for reduced 3β-hydroxysteroid dehydrogenase gene expression in human luteinizing granulosa cells
CN112626220A (en) Biomarker and application thereof
CN108342352B (en) Application of N-carbamylglutamic acid in-vitro culture of porcine follicular granulosa cells
Zhang et al. Hypoxia promotes steroidogenic competence of buffalo (Bubalus bubalis) theca cells
CN112143807A (en) Biomarker and application thereof
JP2021185901A (en) Use of cistanche herb polysaccharides in promoting proliferation and differentiation of female germline stem cells
CN106139147A (en) Mir-27a application in regulation and control follicular development
CN115896032B (en) Yak ovary cumulus cell line and construction method and application thereof
Shirazi et al. Ovine cumulus cells estradiol-17ß production in the presence or absence of oocyte
Lee et al. Effect of sex steroid hormones on bovine myogenic satellite cell proliferation, differentiation and lipid accumulation in myotube

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination